For the quarter ended September 2025, Elanco Animal Health Incorporated (ELAN) reported revenue of $1.14 billion, up 10.4% over the same period last year. EPS came in at $0.19, compared to $0.13 in the year-ago quarter.
The reported revenue represents a surprise of +4.28% over the Zacks Consensus Estimate of $1.09 billion. With the consensus EPS estimate being $0.13, the EPS surprise was +46.15%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Elanco Animal Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:View all Key Company Metrics for Elanco Animal Health here>>>
Shares of Elanco Animal Health have returned +10% over the past month versus the Zacks S&P 500 composite's +1% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| Oct-22 | |
| Oct-20 | |
| Oct-19 | |
| Oct-14 | |
| Oct-07 | |
| Sep-17 | |
| Sep-15 | |
| Sep-11 | |
| Sep-10 | |
| Sep-10 | |
| Aug-31 | |
| Aug-26 |
Elanco celebrates $120 million expansion of Elwood manufacturing facility
ELAN
St. Joseph News-Press, Mo.
|
| Aug-26 | |
| Aug-07 | |
| Aug-06 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite